-
Jan 17, 2025 | 
medicine.washu.edu | Julia Strait |Brittney Wheeler
Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
-
Jan 16, 2025 | 
medicalxpress.com | Julia Strait
Two new studies led by researchers at Washington University School of Medicine in St. Louis have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.
-
Jan 16, 2025 | 
medicine.washu.edu | Julia Strait |Brittney Wheeler
A new type of cell-based immunotherapy shows promise for B-cell lymphomas and — due to innovations in manufacturing — could make future cellular immunotherapies less expensive and more accessible to patients. A phase 1 clinical trial found one such immunotherapy to be safe for patients with several types of B-cell lymphoma, a type of blood cancer.
-
Dec 17, 2024 | 
medicine.washu.edu | Julia Strait
Continuing its role as a leader in leukemia research, Washington University School of Medicine in St. Louis has been awarded a five-year $10.8 million grant to further its exceptional programs in leukemia and other blood cancers. The grant, from the National Cancer Institute (NCI) of the National Institutes of Health (NIH), renews funding for a prestigious Specialized Program of Research Excellence (SPORE) in leukemia.
-
Dec 6, 2024 | 
medicine.washu.edu | Julia Strait |Brittney Wheeler
A new study from Washington University School of Medicine in St. Louis describes an innovative method of analyzing mammograms that significantly improves the accuracy of predicting the risk of breast cancer development over the following five years.
-
Dec 5, 2024 | 
megadoctornews.com | Julia Strait
Mega Doctor NewsByJulia Evangelou Strait / Washington University in St. LouisNewswise – A new study from Washington University School of Medicine in St. Louis describes an innovative method of analyzing mammograms that significantly improves the accuracy of predicting the risk of breast cancer development over the following five years.
-
Dec 5, 2024 | 
medicine.washu.edu | Julia Evangelou Strait |Julia Strait |Brittney Wheeler
Adding a new drug to standard care for stem cell transplant recipients may reduce a life-threatening side effect, according to an early-stage clinical trial conducted at Washington University School of Medicine in St. Louis. The trial showed that patients being treated for various blood cancers tolerated the investigational drug — called itacitinib —and experienced lower-than-expected rates of graft-versus-host disease (GvHD), in which the donor’s stem cells attack the patient’s healthy tissues.
-
Nov 23, 2024 | 
asbmb.org | Julia Strait
To address childhood malnutrition — which affects 200 million children globally — researchers at Washington University School of Medicine in St. Louis developed a therapeutic food that nourishes the collections of beneficial microbes that reside in the gut, and improves children’s growth and other measures of their health. But to understand just how this food therapy works, the research team led by physician-scientist Jeffrey I.
-
Nov 14, 2024 | 
medicalxpress.com | Julia Strait
A small clinical trial shows promising results for patients with triple-negative breast cancer who received an investigational vaccine designed to prevent recurrence of tumors. Conducted at Washington University School of Medicine in St. Louis with a therapy designed by WashU Medicine researchers, the trial is the first to report results for this type of vaccine—known as a neoantigen DNA vaccine—for breast cancer patients.
-
Nov 7, 2024 | 
medicalxpress.com | Julia Strait
Even treated with the most advanced therapies, patients with glioblastoma—an aggressive brain cancer—typically survive less than two years after diagnosis. Efforts to treat this cancer with the latest immunotherapies have been unsuccessful, likely because glioblastoma cells have few—if any—natural targets for the immune system to attack.
